Atossa Therapeutics (MEX:ATOS) Short Interest


MEX:ATOS Atossa Therapeutics Inc MEX:ATOS
28 GF Score
Price MXN31.75
! 2 Warning Signs
View Full Analysis

What is Atossa Therapeutics Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

MEX:ATOS vs LTRN, ESLA, NTRB: Short Interest Comparison

For the Biotechnology subindustry, Atossa Therapeutics's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Atossa Therapeutics Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Atossa Therapeutics's Short Interest distribution charts can be found below:

* The bar in red indicates where Atossa Therapeutics's Short Interest falls into.


MEX:ATOS
28GF Score
Atossa Therapeutics Inc MEX:ATOS
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Atossa Therapeutics Business Description

Other Exchanges ATOS:USAYAG:Germany
Address 1448 NW Market Street, Suite 500, Seattle, WA, USA, 98107
Atossa Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of proprietary medicines for oncology, with a focus on breast cancer and related conditions. The company's lead product candidate, oral (Z)-endoxifen, is a selective estrogen receptor modulator and degrader (SERM/SERD) in Phase 2 clinical development, being evaluated for the treatment and prevention of breast cancer and other indications.
28GF Score

Get the complete analysis for MEX:ATOS

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN31.75
Price